GMDx Genomics

📍 Melbourne CBD, Australia👥 6 employees💰 Last funded Apr 2023
Biotechnology Research🌐 gmdxgenomics.com
Website LinkedIn
GMDx Genomics has developed a genomic Platform Technology that uses validated algorithms to provide a detailed analysis of an individual’s Innate Immune Fitness. The analysis of an individual’s Innate Immune Fitness provides the diagnostic ability to predict an individual’s capability to mount an effective Adaptive Immune Response in a range of disease states. ​ GMDx analyses a Whole Genome Sequence (WGS) from any laboratory source and provides a comprehensive genomic profile on that individual that is in full compliance with all health information privacy regulations. ​ GMDx utilises an industry-leading framework developed by technology stack partners Applied Precision Medicine that is built on the Oracle Autonomous Cloud.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Australia
1
Frequently asked questions
Who invested in GMDx Genomics?
GMDx Genomics has 2 investors on record on gritt.io.
When did GMDx Genomics last raise funding?
The most recent investment in GMDx Genomics recorded on gritt.io was in April 2023.
What industry is GMDx Genomics in?
GMDx Genomics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is GMDx Genomics based?
GMDx Genomics is headquartered in Melbourne CBD, Australia.